Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving pelvic rehabilitation after spinal cord injury with epidural stimulation

Official title: Improving Pelvic Rehabilitation Using Epidural Stimulation After Spinal Cord Injury

Run by University College, London · NCT06515223 · Data updated 2026-11-12

This study is testing if using a special device to stimulate the spinal cord can help people with spinal cord injuries improve their bladder and bowel function through pelvic rehabilitation.

More Spinal Cord Injuries trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity College, London
Academic / other
Locations1 site (Stanmore)
StatusRecruiting
StartedOctober 14, 2024
Main results expectedJanuary 1, 2027
Study endsNovember 1, 2027
Registry record updatedMarch 14, 2025
Trial IDNCT06515223 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 with chronic supra-sacral spinal cord injuries and confirmed neurogenic detrusor overactivity.

Probably not a fit

Patients with transected spinal cords or those with neurodegenerative diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance pelvic rehabilitation for individuals with chronic supra-sacral spinal cord injuries through the use of epidural spinal cord stimulation (eSCS). Participants will undergo implantation of an eSCS device, followed by a series of mapping sessions to optimize stimulation parameters for bladder and bowel function. After a 12-week home program, participants will combine eSCS with pelvic floor muscle training to improve their overall pelvic health. The study will assess the effectiveness of this combined approach in managing neurogenic bladder and bowel issues.

Why it matters

Potential benefit: If successful, this approach could significantly improve bladder and bowel function for patients with spinal cord injuries.

How similar studies have gone: Other studies have shown promise with similar neuromodulation techniques, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Spinal Cord Injury (supra-sacral)
* AIS A-D
* \>18 years;
* SCI sustained \>12 months ago;
* Neurogenic detrusor overactivity (NDO) confirmed on urodynamics;
* Responsive to dorsal genital nerve stimulation
* Willing and able to provide informed consent
* Stable medical, physical and psychological condition as considered by the investigators
* Able to understand and interact with the study team in English
* Sufficient upper limb function to operate the device
* Suitably optimised bladder and bowel routine

Exclusion Criteria:

* Transected cord or SCI related to a neurodegenerative disease
* Any device or metal work in situ that would exclude the patient from having eSCS implanted
* Intra-detrusor botulinum toxin injections within the last 6 months
* Previous surgical intervention on bladder sphincters
* Any diseases and conditions that would exclude the patient from eSCS and/or surgery, for example, degenerative spinal pathology, syrinx and/or tumor.
* Recurrent urinary tract infection refractory to antibiotics
* Women who are pregnant or intending to become pregnant (pregnancy test obligatory for woman of childbearing potential) or breast feeding, or lack of safe contraception for women of childbearing capacity.
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders or dementia of the participant
* Participation in another study with investigational drug within the 30 days preceding and during the present study
* Enrolment of the investigator, his/her family members, employees, and other dependent persons.

Where it's running

  • Royal National Orthopaedic Hospital
    Stanmore, United Kingdom
    Recruiting

Study contacts

  • Principal investigator: David Baxter, MD — National Health Service, United Kingdom
  • Study coordinator: Lynsey Duffell, PhD
  • Email: l.duffell@ucl.ac.uk
  • Phone: 0208 385 3787

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.